• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    DuPont de Nemours Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    10/2/25 4:30:13 PM ET
    $DD
    Major Chemicals
    Industrials
    Get the next $DD alert in real time by email
    8-K
    false 0001666700 0001666700 2025-10-02 2025-10-02
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    FORM 8-K

     

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d)

    of The Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): October 2, 2025

     

     

    DuPont de Nemours, Inc.

    (Exact name of registrant as specified in its charter)

     

     

     

    Delaware   001-38196   81-1224539

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    file number)

     

    (IRS Employer

    Identification No.)

     

    974 Centre Road, Building 730 Wilmington, Delaware 19805
    (Address of Principal Executive Offices) (Zip Code)

    (302) 295-5783

    (Registrant’s Telephone Number, Including Area Code)

    Not applicable

    (Former name or former address, if changed since last report)

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐

    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐

    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐

    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐

    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Title of each class

     

    Trading

    Symbol(s)

     

    Name of each exchange

    on which registered

    Common Stock, par value $0.01 per share   DD   New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     
     


    Item 1.01 Entry into a Material Definitive Agreement

    Consent Solicitations – Third Supplemental Indenture

    DuPont de Nemours, Inc. (“DuPont”) previously announced its offers to exchange (each an “Exchange Offer” and, collectively, the “Exchange Offers”) its outstanding 4.725% Notes due 2028 (the “2028 Notes”), 5.319% Notes due 2038 (the “2038 Notes”) and 5.419% Notes due 2048 (the “2048 Notes” and, collectively with the 2028 Notes and 2038 Notes, the “Existing Notes”) for new notes to be issued by DuPont. As previously announced, concurrently with the Exchange Offers, DuPont also solicited consents from eligible holders of each series of Existing Notes (each, a “Consent Solicitation” and, collectively, the “Consent Solicitations”) to adopt certain proposed amendments to the indenture governing each series of the Existing Notes (the “Proposed Amendments”). The Exchange Offers and Consent Solicitations were made upon the complete terms and subject to the conditions set forth in the confidential Offering Memorandum and Consent Solicitation Statement, dated September 2, 2025, as supplemented by the Supplement No. 1 to such Offering Memorandum and Consent Solicitation Statement, dated as of September 15, 2025, and as amended by the press release issued by DuPont on September 16, 2025 (together, the “Offering Memorandum and Consent Solicitation Statement”).

    The requisite number of consents were received as of 5:00 p.m., New York City time, on September 30, 2025 (the “Expiration Date”) to adopt the Proposed Amendments with respect to the 2028 Notes and, accordingly, the following supplemental indenture to give effect to the Proposed Amendments with respect to the 2028 Notes became operative on October 2, 2025:

     

      •  

    Third Supplemental Indenture, dated as of September 15, 2025, by and between DuPont de Nemours, Inc. (f/k/a DowDuPont Inc.) and U.S. Bank Trust Company, National Association (including as successor in interest to U.S. Bank National Association), as trustee, relating to DuPont’s outstanding 4.725% Notes due 2028.

    The above description of the material terms of the Third Supplemental Indenture does not purport to be complete and is qualified in its entirety by reference to the full text of the Third Supplemental Indenture attached hereto as Exhibit 4.2, the terms of which are in each case incorporated herein by reference. The requisite consents were not received to adopt the Proposed Amendments with respect to DuPont’s 2038 Notes or 2048 Notes, and the Proposed Amendments will not be made with respect to such series of Existing Notes.

    Issuance of Senior Notes

    In connection with the settlement of the Exchange Offers, on October 2, 2025, DuPont issued $1,584,398,000 aggregate principal amount of 4.725% Notes due 2028 (the “New 2028 Notes”) in exchange for the 2028 Notes tendered and accepted by DuPont, $225,963,000 aggregate principal amount of 5.319% Notes due 2038 (the “New 2038 Notes”) in exchange for the 2038 Notes tendered and accepted by DuPont and $294,781,000 aggregate principal amount of 5.419% Notes due 2048 (the “New 2048 Notes” and, collectively with the New 2028 Notes and the New 2038 Notes, the “New Notes”) in exchange for the 2048 Notes tendered and accepted by DuPont.

    The New Notes were issued under an Indenture, dated as of November 28, 2018, by and between DowDuPont Inc. and U.S. Bank National Association, as trustee, as supplemented by the Fourth Supplemental Indenture, dated October 2, 2025, by and between DuPont de Nemours, Inc. and U.S. Bank Trust Company, National Association (as successor in interest to U.S. Bank National Association), as trustee. The New Notes are senior unsecured obligations of DuPont.

    Each series of the New Notes has the same interest rate, interest payment dates, maturity date and optional redemption provisions as the applicable series of Existing Notes; provided that the methodology for calculating any make-whole redemption price for the New Notes will reflect the Securities Industry and Financial Markets Association model provisions. Interest is payable on the New 2028 Notes on May 15 and November 15 of each year beginning on May 15, 2025, until its maturity date of November 15, 2028. Interest is payable on the New 2038 Notes on May 15 and November 15 of each year beginning on May 15, 2025, until its maturity date of November 15, 2038. Interest is payable on the New 2048 Notes on May 15 and November 15 of each year beginning on May 15, 2025, until its maturity date of November 15, 2048.

    If the Intended Electronics Separation is completed on or before March 31, 2026 (the “Special Mandatory Redemption Event”), the Company shall redeem (each redemption, a “Special Mandatory Redemption”) $900,000,000 principal amount of the New 2028 Notes, $225,963,000 principal amount of the New 2038 Notes and $294,781,000 principal amount of the New 2048 Notes on the Special Mandatory Redemption Date (as defined herein) at a redemption price (the “Special Mandatory Redemption Price”) equal to the greater of (1)(a) the sum of the present values of the remaining scheduled payments of principal and interest on each series of the New Notes discounted to the Special Mandatory Redemption Date (assuming each series of the New Notes matured on the applicable par call date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus (i) 25 basis points in the case of the New 2028 Notes and (ii) 30 basis points in the case of the New 2038 Notes and the New 2048 Notes, less (b) interest accrued to the Special Mandatory Redemption Date, and (2) 100% of the principal amount of the applicable series of the New Notes to be redeemed, plus, in either case, accrued and unpaid interest, if any, to, but excluding the Special Mandatory Redemption Date. As used herein, the “Special Mandatory Redemption Date” means the redemption date set forth in the applicable notice of special mandatory redemption with respect to each series of the New Notes.

     


    Additionally, if a change of control triggering event occurs in respect of a series of the New Notes, DuPont will be required to offer to repurchase such series of the New Notes for cash at a purchase price equal to 101% of the principal amount of such series of the New Notes, plus accrued and unpaid interest, if any, to but excluding the date of purchase.

    The above description of the material terms of the Fourth Supplemental Indenture does not purport to be complete and is qualified in its entirety by reference to such to the full text of the Fourth Supplemental Indenture attached hereto as Exhibit 4.3 the terms of which are in each case incorporated herein by reference.

    Registration Rights Agreement

    On October 2, 2025, in connection with the completion of the Exchange Offers, DuPont, Citigroup Global Markets Inc., J.P. Morgan Securities LLC, MUFG Securities Americas Inc. and TD Securities (USA) LLC, collectively, as dealer managers, entered into a registration rights agreement with respect to the New Notes (the “Registration Rights Agreement”). DuPont agreed under the Registration Rights Agreement to, among other things, use its commercially reasonable efforts to (i) file a registration statement on an appropriate registration form with respect to a registered offer to exchange the New Notes for exchange notes, with terms substantially identical in all material respects to the New Notes and (ii) cause such registration statement to become effective under the Securities Act of 1933, as amended. DuPont shall be obligated to pay additional interest on the New Notes if it does not complete the exchange offer on or prior to the 365th day after the issuance of the New Notes, or if the shelf registration statement with respect to the New Notes (if required to be filed) is not declared effective by the later of (i) 180 days after the 365th day after the issuance of the New Notes or (ii) 180 days after the receipt of the relevant request for filing of a shelf registration statement from the dealer managers pursuant to the terms of the Registration Rights Agreement.

    The foregoing summary of the Registration Rights Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Registration Rights Agreement attached as Exhibit 4.7 hereto, the terms of which are incorporated herein by reference.

    Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

    The information included in Item 1.01 of this Current Report on Form 8-K is incorporated into this Item 2.03 by reference.

    Item 9.01. Financial Statements and Exhibits.

    (d) Exhibits

     

    Exhibit
    No.
      

    Exhibit

    4.2    Third Supplemental Indenture, dated September 15, 2025, by and between DuPont de Nemours, Inc. and U.S. Bank Trust Company, National Association, as trustee.
    4.3    Fourth Supplemental Indenture, dated October 2, 2025, by and between DuPont de Nemours, Inc. and U.S. Bank Trust Company, National Association, as trustee.
    4.4    Form of 4.725% Notes due 2028 (included in Exhibit 4.3)
    4.5    Form of 5.319% Notes due 2038 (included in Exhibit 4.3)
    4.6    Form of 5.419% Notes due 2048 (included in Exhibit 4.3)
    4.7    Registration Rights Agreement, dated October 2, 2025, by and between DuPont de Nemours, Inc. and Citigroup Global Markets Inc., J.P. Morgan Securities LLC, MUFG Securities Americas Inc. and TD Securities (USA) LLC, collectively, as dealer managers.
    104    Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document).

     


    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

            DUPONT DE NEMOURS, INC.
        Registrant
    Date: October 2, 2025  

     

      By:  

    /s/ Erik T. Hoover

        Name:   Erik T. Hoover
        Title:   Senior Vice President and General Counsel
    Get the next $DD alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $DD

    DatePrice TargetRatingAnalyst
    7/3/2025$75.00 → $85.00Buy
    Citigroup
    4/15/2025$75.00Underperform → Neutral
    BofA Securities
    4/14/2025$81.00Sector Weight → Overweight
    KeyBanc Capital Markets
    2/13/2025$85.00 → $89.00Underweight → Equal Weight
    Barclays
    1/17/2025$91.00Peer Perform → Outperform
    Wolfe Research
    10/7/2024$88.00 → $84.00Equal Weight → Underweight
    Barclays
    5/28/2024$85.00 → $95.00Neutral → Buy
    Citigroup
    5/24/2024$80.00 → $103.00Equal Weight → Overweight
    Wells Fargo
    More analyst ratings

    $DD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DuPont Announces 2025 Lavoisier Medal and Pedersen Award Recipients

    Five DuPont scientists and engineers honored for innovations that have made significant contributions to the company, customers, industries and the world. WILMINGTON, Del., Oct. 2, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the recipients of the 2025 Lavoisier Medal for Lifetime Technical Achievement and the Pedersen Award. The 2025 Lavoisier Medalists are Steve Jons, Senior Laureate, Water Solutions and Sourav Sengupta, Laureate, Engineering. The Lavoisier Medal for Lifetime Technical Achievement recognizes scientists and engineers who have demonstrated a career o

    10/2/25 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Effectiveness of Form 10 Registration Statement for Qnity

    WILMINGTON, Del., Oct. 1, 2025 /PRNewswire/ -- DuPont (NYSE:DD) announced today that on September 30, 2025, the U.S. Securities and Exchange Commission (SEC) declared effective the Registration Statement on Form 10 filed by Qnity Electronics, Inc. ("Qnity") in connection with DuPont's previously announced separation into two independent, publicly traded companies. The effectiveness of the Form 10 concludes the SEC's review and is one of the final milestones in the separation process. The separation remains on track to occur on November 1, 2025, subject to satisfaction of custo

    10/1/25 7:45:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Final Results of Exchange Offers and Consent Solicitations for Senior Notes

    WILMINGTON, Del., Oct. 1, 2025 /PRNewswire/ -- DuPont de Nemours, Inc. (NYSE:DD) ("DuPont") announced today the final results of its previously announced offers to exchange (each an "Exchange Offer" and, collectively, the "Exchange Offers") any and all of its outstanding (i) 4.725% Notes due 2028 (the "2028 Notes"), (ii) 5.319% Notes due 2038 (the "2038 Notes") and (iii) 5.419% Notes due 2048 (the "2048 Notes" and, collectively with the 2028 Notes and 2038 Notes, the "Existing Notes") for new notes to be issued by DuPont (the "New Notes"). Concurrently with the Exchange Offers, DuPont also solicited consents from eligible holders of each series of Existing Notes (each, a "Consent Solicitatio

    10/1/25 6:45:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup reiterated coverage on DuPont with a new price target

    Citigroup reiterated coverage of DuPont with a rating of Buy and set a new price target of $85.00 from $75.00 previously

    7/3/25 9:18:04 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by BofA Securities with a new price target

    BofA Securities upgraded DuPont from Underperform to Neutral and set a new price target of $75.00

    4/15/25 8:43:17 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont upgraded by KeyBanc Capital Markets with a new price target

    KeyBanc Capital Markets upgraded DuPont from Sector Weight to Overweight and set a new price target of $81.00

    4/14/25 8:04:47 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    SEC Filings

    View All

    DuPont de Nemours Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    10/2/25 4:30:13 PM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form 8-K filed by DuPont de Nemours Inc.

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    9/16/25 8:58:23 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form 8-K filed by DuPont de Nemours Inc.

    8-K - DuPont de Nemours, Inc. (0001666700) (Filer)

    9/2/25 6:05:30 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Dupont De Nemours, Inc. claimed ownership of 100 shares (SEC Form 3)

    3 - DuPont de Nemours, Inc. (0001666700) (Reporting)

    9/30/25 6:29:45 PM ET
    $DD
    Major Chemicals
    Industrials

    SVP & CIO Larrabee Steven P. exercised 39,208 shares at a strike of $61.71 and sold $3,334,386 worth of shares (43,208 units at $77.17), decreasing direct ownership by 9% to 38,585 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    9/17/25 4:36:46 PM ET
    $DD
    Major Chemicals
    Industrials

    SVP & CIO Larrabee Steven P. exercised 25,000 shares at a strike of $66.06 and sold $2,380,500 worth of shares (31,000 units at $76.79), decreasing direct ownership by 12% to 42,585 units (SEC Form 4)

    4 - DuPont de Nemours, Inc. (0001666700) (Issuer)

    9/9/25 7:20:45 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Financials

    Live finance-specific insights

    View All

    DuPont Reports Second Quarter 2025 Results

    Net Sales of $3.3 billion increased 3%; organic sales increased 2% versus year-ago periodGAAP Income from continuing operations of $238 million; operating EBITDA of $859 millionGAAP EPS from continuing operations of $0.54; adjusted EPS of $1.12Cash provided by operating activities from continuing operations of $381 million; transaction- adjusted free cash flow of $433 millionFull year 2025 guidance raised on stronger second quarter performanceWILMINGTON, Del., Aug. 5, 2025 /PRNewswire/ -- DuPont (NYSE:DD) announced its financial results(1) for the second quarter ended June 30, 2025.

    8/5/25 6:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Schedules Second Quarter 2025 Earnings Conference Call

    WILMINGTON, Del., July 22, 2025 /PRNewswire/ -- DuPont (NYSE:DD) will release its second quarter financial results at 6:00 a.m. ET on Tuesday, August 5, 2025. In addition, the company will host a conference call at 8:00 a.m. ET that day. The event will be webcast live and can be accessed on DuPont's Investors Relations webpage. A replay, along with the earnings release and supporting materials, will also be posted to the website.        The dial-in number for the conference call is 888-440-4172 toll-free within the U.S. or +1-646-960-0673. The conference ID is 5994046. About D

    7/22/25 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Publishes 2025 Sustainability Report

    Report highlights strong progress on 2030 Sustainability Goals focused on value creation and risk reduction, with significant achievements on climate action WILMINGTON, Del., July 22, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today published its 2025 Sustainability Report detailing the progress made toward achieving its 2030 Sustainability Goals. "At DuPont, innovation and sustainability are deeply interconnected—and that's reflected in the strong results we've delivered," said Lori Koch, DuPont Chief Executive Officer. "This past year, our teams advanced breakthrough technologies

    7/22/25 8:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Leadership Updates

    Live Leadership Updates

    View All

    DuPont Announces Appointment of Kurt McMaken to Board of Directors

    WILMINGTON, Del., Feb. 21, 2025 /PRNewswire/ -- DuPont (NYSE:DD) today announced the appointment of Kurt McMaken to its Board of Directors, effective immediately. Mr. McMaken will serve on the Audit committee and Nomination and Governance committee. "We are pleased to welcome Kurt to DuPont's Board of Directors," said DuPont Executive Chairman Ed Breen. "Kurt's global business expertise in the manufacturing sector and extensive background in finance and strategic planning make him well suited to help guide DuPont's growth and value creation strategies. We look forward to his c

    2/21/25 4:15:00 PM ET
    $DD
    Major Chemicals
    Industrials

    DuPont Announces Two Technology Leaders as DuPont Laureates

    Dr. Deyan Wang and Nicholas Sands Recognized for a Career of Innovation and Business Impact; Achieve Highest Technical Level in the Company WILMINGTON, Del., Oct. 10, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced that two of its technology leaders have achieved the professional distinction of DuPont Laureate, the company's most distinguished technical designation. The newly appointed Laureates are Dr. Deyan Wang, DuPont Electronics & Industrial and Nicholas (Nick) Sands of DuPont Water & Protection. "I'm tremendously honored to recognize Deyan and Nick, two of DuPont's

    10/10/24 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    DuPont to Acquire Donatelle Plastics Incorporated

    Transaction deepens healthcare offerings in medical device solutions WILMINGTON, Del., June 25, 2024 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has signed an agreement to acquire Donatelle Plastics Incorporated, a leading medical device contract manufacturer specializing in the design, development and manufacture of medical components and devices. The transaction is expected to close in the third quarter 2024, subject to satisfaction of customary closing conditions and receipt of regulatory approvals. "Our healthcare strategy is focused on offering a comprehensive sui

    6/25/24 9:00:00 AM ET
    $DD
    Major Chemicals
    Industrials

    $DD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by DuPont de Nemours Inc.

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    11/12/24 11:54:03 AM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G/A filed by DuPont de Nemours Inc. (Amendment)

    SC 13G/A - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/13/24 4:55:53 PM ET
    $DD
    Major Chemicals
    Industrials

    SEC Form SC 13G filed by DuPont de Nemours Inc.

    SC 13G - DuPont de Nemours, Inc. (0001666700) (Subject)

    2/9/24 11:49:03 AM ET
    $DD
    Major Chemicals
    Industrials